Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Insperity (NSP) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Insperity and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Nov. 01, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar Eagel & Squire, P.C., a nationally recog ...

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In James Hardie (JHX) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in James Hardie and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Oct. 09, 2025 (GLOBE NEWSWIRE) -- What’s Happening: Bragar Eagel & Squire, P.C., a nationally ...

公司调查 - 律师事务所Bragar Eagel & Squire正在调查BellRing Brands是否违反联邦证券法或其他非法商业行为 [1] - 调查针对BellRing Brands的股东权益问题 [1] 财务表现 - BellRing Brands在2025年第二季度财报电话会议中披露客户正通过降低库存周数来"优化"库存 这将导致第三季度销售增长放缓至"低个位数" [2] - 该消息导致公司股价下跌近19% [2] 股东行动 - 股东如因购买或持有BellRing Brands股票遭受损失可联系律师事务所了解索赔详情 [3] - 律师事务所提供免费咨询且无任何费用或义务 [3] 律师事务所信息 - Bragar Eagel & Squire是一家全国性律师事务所 在纽约和加州设有办公室 [4] - 该律所专注于证券诉讼和复杂商业诉讼 代表个人和机构投资者 [4]

公司调查 - Schall Law Firm宣布正在调查Capricor Therapeutics可能违反证券法的行为 [1] - 调查重点在于公司是否发布虚假或误导性声明或未披露关键投资者信息 [2] 产品审批进展 - Capricor于2025年5月5日宣布完成FDA对deramiocel（治疗杜氏肌营养不良心肌病的细胞疗法）生物制剂许可申请的中期审查会议 [2] - FDA确认将针对该申请召开咨询委员会会议 [2]